+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Viral Inactivation Market - Global Forecast 2026-2032- Product Image
Viral Inactivation Market - Global Forecast 2026-2032- Product Image
New

Viral Inactivation Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 186 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4986084
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Viral inactivation solutions are at the forefront of safeguarding operations in industries exposed to infectious agents. As technology evolves and organizations prioritize risk management, leaders must navigate increasing complexity in order to implement proven, compliant systems that meet diverse operational demands.

Market Snapshot: Viral Inactivation Market Size and Growth

The Viral Inactivation Market is experiencing consistent growth, valued at USD 786.30 million in 2025 and projected to reach USD 863.85 million in 2026, marking a compound annual growth rate (CAGR) of 9.50%. This market is expected to achieve USD 1.48 billion by 2032. Market momentum is fueled by the rising need for validated viral inactivation solutions across healthcare, pharmaceutical manufacturing, food processing, and industrial sanitation. Procurement complexities and heightened compliance standards are driving heightened adoption worldwide, as organizations seek reliable ways to ensure public health and safety amid a dynamic regulatory environment.

Scope & Segmentation

  • Product Types: Comprises consumables such as chemical kits, disinfectant solutions, and UV lamps alongside equipment like filtration systems, irradiation platforms, and sterilization tools. These address both recurring and long-term operational needs.
  • Methods: Includes chemical treatments—such as chlorine dioxide, ethylene oxide, and hydrogen peroxide—thermal approaches involving dry and moist heat, and physical techniques such as electron beam, gamma radiation, and various ultraviolet light modalities.
  • Applications: Covers air purification systems intended for HVAC and standalone use, food and beverage process sanitation, pharmaceutical manufacturing for APIs, biologics, and vaccines, as well as safe treatment of drinking water and wastewater.
  • End Users: Encompasses biotechnology organizations focused on diagnostics and therapeutics, producers within food and beverage sectors, clinics and hospitals, and a range of research and clinical laboratories, each requiring customized solutions.
  • Regions: Demonstrates significant adoption in the Americas with a focus on digital compliance and resilience, continued regulatory enhancements and uptake of energy-efficient technologies in EMEA, and growing scalability and integration with manufacturing processes in Asia-Pacific.
  • Core Technologies: Spans filtration advancements, irradiation systems, refined chemical formulations, modular platforms, and enhanced interoperability which empower flexible investment choices and efficient deployment for end users.

Key Takeaways

  • Organizations are prioritizing solution efficacy, safety, and operational scalability to respond to rapidly evolving infectious risk and compliance parameters.
  • Technological convergence is leading to integrated deployment models, bringing together chemical, heat-based, and physical inactivation approaches for broader protection.
  • Increasing regulatory focus on validation and traceability is prompting shifts toward interoperable, digitally-monitored viral inactivation systems for streamlined compliance.
  • Supplier diversification and heightened inventory visibility have become integral to mitigating risk, supporting uninterrupted operations, and reducing supply chain exposure.
  • Collaboration among manufacturers, certification entities, and integration partners helps accelerate implementation and enables cross-functional system validation to meet distinct technical needs.
  • Transition to service-led business models—including ongoing validation services, installation, and training—supports client retention and underpins recurring revenue strategies for technology providers.

Tariff Impact: Shaping Sourcing and Resilience Strategies

With the introduction of United States tariffs in 2025, companies reassessed sourcing models and diversified supply chains to mitigate rising material costs. This shift resulted in accelerated localization efforts, new supplier partnerships, and adoption of alternative procurement channels. Distributors and end users adopted forward-buying and renegotiated contracts, aiming for stability and cost control. Manufacturers also introduced modular product designs that offer flexibility, necessitating additional qualification and validation steps before mainstream implementation. These changes support sustainable competitive positioning and resilient supply networks.

Methodology & Data Sources

This report utilizes a robust mixed-method approach, combining primary interviews with procurement and technical leaders, on-site operations reviews, and detailed analysis of regulatory and technical documentation. Expert consultations ensure that insights accurately reflect practical considerations and real-world applications within the viral inactivation solutions landscape.

Why This Report Matters

  • Provides actionable insight into technology developments, compliance trends, and evolving supply chain strategies influencing procurement for viral inactivation solutions.
  • Enables benchmarking of product options and operational models, allowing organizations to make informed investment and supplier decisions aligned to their needs.
  • Supports executives and procurement leaders in aligning solution strategies with regional, application-specific, and validation requirements.

Conclusion

Validated, multi-modal viral inactivation solutions remain pivotal for operational resilience and health protection. Decision-makers utilizing these market insights can prioritize flexible, interoperable systems and collaborative partnerships for enduring organizational benefit.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Viral Inactivation Market, by Product
8.1. Consumables
8.1.1. Chemical Kits
8.1.2. Disinfectant Solutions
8.1.3. Uv Lamps
8.2. Equipment
8.2.1. Filtration Equipment
8.2.2. Irradiation Equipment
8.2.3. Sterilization Equipment
9. Viral Inactivation Market, by Method
9.1. Chemical Treatment
9.1.1. Chlorine Dioxide
9.1.2. Ethylene Oxide
9.1.3. Hydrogen Peroxide
9.2. Heat Treatment
9.2.1. Dry Heat
9.2.2. Moist Heat
9.3. Physical Treatment
9.3.1. Electron Beam
9.3.2. Gamma Radiation
9.3.3. Ultraviolet
9.3.3.1. Low Pressure Mercury
9.3.3.2. Pulsed Xenon
10. Viral Inactivation Market, by Application
10.1. Air Purification
10.1.1. Hvac Systems
10.1.2. Portable Purifiers
10.2. Food Processing
10.2.1. Beverage Processing
10.2.2. Dairy Processing
10.2.3. Meat Processing
10.3. Pharmaceutical Manufacturing
10.3.1. API Production
10.3.2. Biologics Production
10.3.3. Vaccine Production
10.4. Water Treatment
10.4.1. Drinking Water Treatment
10.4.2. Wastewater Treatment
11. Viral Inactivation Market, by End User
11.1. Biotechnology Firms
11.1.1. Diagnostic Developers
11.1.2. Therapeutics Developers
11.2. Food And Beverage Processors
11.2.1. Beverage Plants
11.2.2. Dairy Plants
11.2.3. Meat Plants
11.3. Healthcare Facilities
11.3.1. Clinics
11.3.2. Hospitals
11.4. Laboratories
11.4.1. Clinical Laboratories
11.4.2. Research Laboratories
12. Viral Inactivation Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Viral Inactivation Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Viral Inactivation Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Viral Inactivation Market
16. China Viral Inactivation Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Asahi Kasei Medical
17.6. Charles River Laboratories International, Inc.
17.7. Clean Cells Inc.
17.8. Cytiva
17.9. Danaher Corporation
17.10. Eurofins Scientific SE
17.11. Kedrion
17.12. Lonza Group AG
17.13. Merck KGaA
17.14. Pall Corporation
17.15. Parker Hannifin Corporation
17.16. Rad Source Technologies, Inc.
17.17. Sartorius AG
17.18. Texcell SA
17.19. Thermo Fisher Scientific Inc.
17.20. Vironova AB
17.21. WuXi AppTec
17.22. WuXi Biologics
List of Figures
FIGURE 1. GLOBAL VIRAL INACTIVATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL VIRAL INACTIVATION MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL VIRAL INACTIVATION MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES VIRAL INACTIVATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA VIRAL INACTIVATION MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL VIRAL INACTIVATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY CHEMICAL KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY CHEMICAL KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY CHEMICAL KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY DISINFECTANT SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY DISINFECTANT SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY DISINFECTANT SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY UV LAMPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY UV LAMPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY UV LAMPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY FILTRATION EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY FILTRATION EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY FILTRATION EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY IRRADIATION EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY IRRADIATION EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY IRRADIATION EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY STERILIZATION EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY STERILIZATION EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY STERILIZATION EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY CHEMICAL TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY CHEMICAL TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY CHEMICAL TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY CHEMICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY CHLORINE DIOXIDE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY CHLORINE DIOXIDE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY CHLORINE DIOXIDE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY ETHYLENE OXIDE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY ETHYLENE OXIDE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY ETHYLENE OXIDE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY HYDROGEN PEROXIDE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY HYDROGEN PEROXIDE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY HYDROGEN PEROXIDE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY HEAT TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY HEAT TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY HEAT TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY HEAT TREATMENT, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY DRY HEAT, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY DRY HEAT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY DRY HEAT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY MOIST HEAT, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY MOIST HEAT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY MOIST HEAT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY PHYSICAL TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY PHYSICAL TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY PHYSICAL TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY PHYSICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY ELECTRON BEAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY ELECTRON BEAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY ELECTRON BEAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY GAMMA RADIATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY GAMMA RADIATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY GAMMA RADIATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY ULTRAVIOLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY ULTRAVIOLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY ULTRAVIOLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY ULTRAVIOLET, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY LOW PRESSURE MERCURY, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY LOW PRESSURE MERCURY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY LOW PRESSURE MERCURY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY PULSED XENON, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY PULSED XENON, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY PULSED XENON, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY AIR PURIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY AIR PURIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY AIR PURIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY AIR PURIFICATION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY HVAC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY HVAC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY HVAC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY PORTABLE PURIFIERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY PORTABLE PURIFIERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY PORTABLE PURIFIERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY FOOD PROCESSING, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY FOOD PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY FOOD PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY FOOD PROCESSING, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY BEVERAGE PROCESSING, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY BEVERAGE PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY BEVERAGE PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY DAIRY PROCESSING, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY DAIRY PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY DAIRY PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY MEAT PROCESSING, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY MEAT PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY MEAT PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY API PRODUCTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY API PRODUCTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY API PRODUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY BIOLOGICS PRODUCTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY BIOLOGICS PRODUCTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY BIOLOGICS PRODUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY VACCINE PRODUCTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY VACCINE PRODUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY WATER TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY WATER TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY WATER TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY WATER TREATMENT, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY DRINKING WATER TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY DRINKING WATER TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY DRINKING WATER TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY WASTEWATER TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY WASTEWATER TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY WASTEWATER TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY BIOTECHNOLOGY FIRMS, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY DIAGNOSTIC DEVELOPERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY DIAGNOSTIC DEVELOPERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY DIAGNOSTIC DEVELOPERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY THERAPEUTICS DEVELOPERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY THERAPEUTICS DEVELOPERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY THERAPEUTICS DEVELOPERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY FOOD AND BEVERAGE PROCESSORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY FOOD AND BEVERAGE PROCESSORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY FOOD AND BEVERAGE PROCESSORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY FOOD AND BEVERAGE PROCESSORS, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY BEVERAGE PLANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY BEVERAGE PLANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY BEVERAGE PLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY DAIRY PLANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY DAIRY PLANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY DAIRY PLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY MEAT PLANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY MEAT PLANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY MEAT PLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY HEALTHCARE FACILITIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY HEALTHCARE FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY HEALTHCARE FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY LABORATORIES, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY CLINICAL LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY CLINICAL LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 165. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 166. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 167. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 168. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 169. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2032 (USD MILLION)
TABLE 170. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY CHEMICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 171. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY HEAT TREATMENT, 2018-2032 (USD MILLION)
TABLE 172. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY PHYSICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 173. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY ULTRAVIOLET, 2018-2032 (USD MILLION)
TABLE 174. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 175. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY AIR PURIFICATION, 2018-2032 (USD MILLION)
TABLE 176. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY FOOD PROCESSING, 2018-2032 (USD MILLION)
TABLE 177. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 178. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY WATER TREATMENT, 2018-2032 (USD MILLION)
TABLE 179. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY BIOTECHNOLOGY FIRMS, 2018-2032 (USD MILLION)
TABLE 181. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY FOOD AND BEVERAGE PROCESSORS, 2018-2032 (USD MILLION)
TABLE 182. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2032 (USD MILLION)
TABLE 183. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY LABORATORIES, 2018-2032 (USD MILLION)
TABLE 184. NORTH AMERICA VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 185. NORTH AMERICA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 186. NORTH AMERICA VIRAL INACTIVATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 187. NORTH AMERICA VIRAL INACTIVATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 188. NORTH AMERICA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2032 (USD MILLION)
TABLE 189. NORTH AMERICA VIRAL INACTIVATION MARKET SIZE, BY CHEMICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 190. NORTH AMERICA VIRAL INACTIVATION MARKET SIZE, BY HEAT TREATMENT, 2018-2032 (USD MILLION)
TABLE 191. NORTH AMERICA VIRAL INACTIVATION MARKET SIZE, BY PHYSICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 192. NORTH AMERICA VIRAL INACTIVATION MARKET SIZE, BY ULTRAVIOLET, 2018-2032 (USD MILLION)
TABLE 193. NORTH AMERICA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 194. NORTH AMERICA VIRAL INACTIVATION MARKET SIZE, BY AIR PURIFICATION, 2018-2032 (USD MILLION)
TABLE 195. NORTH AMERICA VIRAL INACTIVATION MARKET SIZE, BY FOOD PROCESSING, 2018-2032 (USD MILLION)
TABLE 196. NORTH AMERICA VIRAL INACTIVATION MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 197. NORTH AMERICA VIRAL INACTIVATION MARKET SIZE, BY WATER TREATMENT, 2018-2032 (USD MILLION)
TABLE 198. NORTH AMERICA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 199. NORTH AMERICA VIRAL INACTIVATION MARKET SIZE, BY BIOTECHNOLOGY FIRMS, 2018-2032 (USD MILLION)
TABLE 200. NORTH AMERICA VIRAL INACTIVATION MARKET SIZE, BY FOOD AND BEVERAGE PROCESSORS, 2018-2032 (USD MILLION)
TABLE 201. NORTH AMERICA VIRAL INACTIVATION MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2032 (USD MILLION)
TABLE 202. NORTH AMERICA VIRAL INACTIVATION MARKET SIZE, BY LABORATORIES, 2018-2032 (USD MILLION)
TABLE 203. LATIN AMERICA VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 204. LATIN AMERICA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 205. LATIN AMERICA VIRAL INACTIVATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 206. LATIN AMERICA VIRAL INACTIVATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 207. LATIN AMERICA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2032 (USD MILLION)
TABLE 208. LATIN AMERICA VIRAL INACTIVATION MARKET SIZE, BY CHEMICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 209. LATIN AMERICA VIRAL INACTIVATION MARKET SIZE, BY HEAT TREATMENT, 2018-2032 (USD MILLION)
TABLE 210. LATIN AMERICA VIRAL INACTIVATION MARKET SIZE, BY PHYSICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 211. LATIN AMERICA VIRAL INACTIVATION MARKET SIZE, BY ULTRAVIOLET, 2018-2032 (USD MILLION)
TABLE 212. LATIN AMERICA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 213. LATIN AMERICA VIRAL INACTIVATION MARKET SIZE, BY AIR PURIFICATION, 2018-2032 (USD MILLION)
TABLE 214. LATIN AMERICA VIRAL INACTIVATION MARKET SIZE, BY FOOD PROCESSING, 2018-2032 (USD MILLION)
TABLE 215. LATIN AMERICA VIRAL INACTIVATION MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 216. LATIN AMERICA VIRAL INACTIVATION MARKET SIZE, BY WATER TREATMENT, 2018-2032 (USD MILLION)
TABLE 217. LATIN AMERICA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 218. LATIN AMERICA VIRAL INACTIVATION MARKET SIZE, BY BIOTECHNOLOGY FIRMS, 2018-2032 (USD MILLION)
TABLE 219. LATIN AMERICA VIRAL INACTIVATION MARKET SIZE, BY FOOD AND BEVERAGE PROCESSORS, 2018-2032 (USD MILLION)
TABLE 220. LATIN AMERICA VIRAL INACTIVATION MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2032 (USD MILLION)
TABLE 221. LATIN AMERICA VIRAL INACTIVATION MARKET SIZE, BY LABORATORIES, 2018-2032 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2032 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY CHEMICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY HEAT TREATMENT, 2018-2032 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY PHYSICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY ULTRAVIOLET, 2018-2032 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY AIR PURIFICATION, 2018-2032 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY FOOD PROCESSING, 2018-2032 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY WATER TREATMENT, 2018-2032 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY BIOTECHNOLOGY FIRMS, 2018-2032 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY FOOD AND BEVERAGE PROCESSORS, 2018-2032 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2032 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY LABORATORIES, 2018-2032 (USD MILLION)
TABLE 241. EUROPE VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 242. EUROPE VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 243. EUROPE VIRAL INACTIVATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 244. EUROPE VIRAL INACTIVATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 245. EUROPE VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2032 (USD MILLION)
TABLE 246. EUROPE VIRAL INACTIVATION MARKET SIZE, BY CHEMICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 247. EUROPE VIRAL INACTIVATION MARKET SIZE, BY HEAT TREATMENT, 2018-2032 (USD MILLION)
TABLE 248. EUROPE VIRAL INACTIVATION MARKET SIZE, BY PHYSICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 249. EUROPE VIRAL INACTIVATION MARKET SIZE, BY ULTRAVIOLET, 2018-2032 (USD MILLION)
TABLE 250. EUROPE VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 251. EUROPE VIRAL INACTIVATION MARKET SIZE, BY AIR PURIFICATION, 2018-2032 (USD MILLION)
TABLE 252. EUROPE VIRAL INACTIVATION MARKET SIZE, BY FOOD PROCESSING, 2018-2032 (USD MILLION)
TABLE 253. EUROPE VIRAL INACTIVATION MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 254. EUROPE VIRAL INACTIVATION MARKET SIZE, BY WATER TREATMENT, 2018-2032 (USD MILLION)
TABLE 255. EUROPE VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 256. EUROPE VIRAL INACTIVATION MARKET SIZE, BY BIOTECHNOLOGY FIRMS, 2018-2032 (USD MILLION)
TABLE 257. EUROPE VIRAL INACTIVATION MARKET SIZE, BY FOOD AND BEVERAGE PROCESSORS, 2018-2032 (USD MILLION)
TABLE 258. EUROPE VIRAL INACTIVATION MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2032 (USD MILLION)
TABLE 259. EUROPE VIRAL INACTIVATION MARKET SIZE, BY LABORATORIES, 2018-2032 (USD MILLION)
TABLE 260. MIDDLE EAST VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 261. MIDDLE EAST VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 262. MIDDLE EAST VIRAL INACTIVATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 263. MIDDLE EAST VIRAL INACTIVATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 264. MIDDLE EAST VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2032 (USD MILLION)
TABLE 265. MIDDLE EAST VIRAL INACTIVATION MARKET SIZE, BY CHEMICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 266. MIDDLE EAST VIRAL INACTIVATION MARKET SIZE, BY HEAT TREATMENT, 2018-2032 (USD MILLION)
TABLE 267. MIDDLE EAST VIRAL INACTIVATION MARKET SIZE, BY PHYSICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 268. MIDDLE EAST VIRAL INACTIVATION MARKET SIZE, BY ULTRAVIOLET, 2018-2032 (USD MILLION)
TABLE 269. MIDDLE EAST VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 270. MIDDLE EAST VIRAL INACTIVATION MARKET SIZE, BY AIR PURIFICATION, 2018-2032 (USD MILLION)
TABLE 271. MIDDLE EAST VIRAL INACTIVATION MARKET SIZE, BY FOOD PROCESSING, 2018-2032 (USD MILLION)
TABLE 272. MIDDLE EAST VIRAL INACTIVATION MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 273. MIDDLE EAST VIRAL INACTIVATION MARKET SIZE, BY WATER TREATMENT, 2018-2032 (USD MILLION)
TABLE 274. MIDDLE EAST VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 275. MIDDLE EAST VIRAL INACTIVATION MARKET SIZE, BY BIOTECHNOLOGY FIRMS, 2018-2032 (USD MILLION)
TABLE 276. MIDDLE EAST VIRAL INACTIVATION MARKET SIZE, BY FOOD AND BEVERAGE PROCESSORS, 2018-2032 (USD MILLION)
TABLE 277. MIDDLE EAST VIRAL INACTIVATION MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2032 (USD MILLION)
TABLE 278. MIDDLE EAST VIRAL INACTIVATION MARKET SIZE, BY LABORATORIES, 2018-2032 (USD MILLION)
TABLE 279. AFRICA VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 280. AFRICA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 281. AFRICA VIRAL INACTIVATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 282. AFRICA VIRAL INACTIVATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 283. AFRICA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2032 (USD MILLION)
TABLE 284. AFRICA VIRAL INACTIVATION MARKET SIZE, BY CHEMICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 285. AFRICA VIRAL INACTIVATION MARKET SIZE, BY HEAT TREATMENT, 2018-2032 (USD MILLION)
TABLE 286. AFRICA VIRAL INACTIVATION MARKET SIZE, BY PHYSICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 287. AFRICA VIRAL INACTIVATION MARKET SIZE, BY ULTRAVIOLET, 2018-2032 (USD MILLION)
TABLE 288. AFRICA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 289. AFRICA VIRAL INACTIVATION MARKET SIZE, BY AIR PURIFICATION, 2018-2032 (USD MILLION)
TABLE 290. AFRICA VIRAL INACTIVATION MARKET SIZE, BY FOOD PROCESSING, 2018-2032 (USD MILLION)
TABLE 291. AFRICA VIRAL INACTIVATION MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 292. AFRICA VIRAL INACTIVATION MARKET SIZE, BY WATER TREATMENT, 2018-2032 (USD MILLION)
TABLE 293. AFRICA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 294. AFRICA VIRAL INACTIVATION MARKET SIZE, BY BIOTECHNOLOGY FIRMS, 2018-2032 (USD MILLION)
TABLE 295. AFRICA VIRAL INACTIVATION MARKET SIZE, BY FOOD AND BEVERAGE PROCESSORS, 2018-2032 (USD MILLION)
TABLE 296. AFRICA VIRAL INACTIVATION MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2032 (USD MILLION)
TABLE 297. AFRICA VIRAL INACTIVATION MARKET SIZE, BY LABORATORIES, 2018-2032 (USD MILLION)
TABLE 298. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 299. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 300. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 301. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 302. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2032 (USD MILLION)
TABLE 303. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY CHEMICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 304. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY HEAT TREATMENT, 2018-2032 (USD MILLION)
TABLE 305. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY PHYSICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 306. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY ULTRAVIOLET, 2018-2032 (USD MILLION)
TABLE 307. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 308. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY AIR PURIFICATION, 2018-2032 (USD MILLION)
TABLE 309. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY FOOD PROCESSING, 2018-2032 (USD MILLION)
TABLE 310. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 311. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY WATER TREATMENT, 2018-2032 (USD MILLION)
TABLE 312. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 313. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY BIOTECHNOLOGY FIRMS, 2018-2032 (USD MILLION)
TABLE 314. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY FOOD AND BEVERAGE PROCESSORS, 2018-2032 (USD MILLION)
TABLE 315. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2032 (USD MILLION)
TABLE 316. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY LABORATORIES, 2018-2032 (USD MILLION)
TABLE 317. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 318. ASEAN VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 319. ASEAN VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 320. ASEAN VIRAL INACTIVATION MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 321. ASEAN VIRAL INACTIVATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 322. ASEAN VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2032 (USD MILLION)
TABLE 323. ASEAN VIRAL INACTIVATION MARKET SIZE, BY CHEMICAL TREATM

Companies Mentioned

The key companies profiled in this Viral Inactivation market report include:
  • Asahi Kasei Medical
  • Charles River Laboratories International, Inc.
  • Clean Cells Inc.
  • Cytiva
  • Danaher Corporation
  • Eurofins Scientific SE
  • Kedrion
  • Lonza Group AG
  • Merck KGaA
  • Pall Corporation
  • Parker Hannifin Corporation
  • Rad Source Technologies, Inc.
  • Sartorius AG
  • Texcell SA
  • Thermo Fisher Scientific Inc.
  • Vironova AB
  • WuXi AppTec
  • WuXi Biologics

Table Information

Report AttributeDetails
No. of Pages186
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 863.85 Million
Forecasted Market Value ( USD ) by 2032 $ 1480 Million
Compound Annual Growth Rate9.5%
Regions CoveredGlobal
No. of Companies Mentioned19

Related Topics

Related Reports

Medical Device Viral Inactivation Testing Market - Global Forecast 2026-2032 - Product Image

Medical Device Viral Inactivation Testing Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Viral Inactivation Market Report by Product, Application, End Use, and Region 2025-2033 - Product Image

Viral Inactivation Market Report by Product, Application, End Use, and Region 2025-2033

  • Report
  • 148 Pages
  • Global
From
Viral Inactivation Market Report 2025 - Product Image

Viral Inactivation Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Viral Inactivation - Global Strategic Business Report - Product Image

Viral Inactivation - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From
2025 Global Forecast for Viral Inactivation Market (2026-2031): High Tech Outlook Report - Product Image

2025 Global Forecast for Viral Inactivation Market (2026-2031): High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From

About the Viral Inactivation Market

The Viral Inactivation market is a subset of the biotechnology industry that focuses on the development of technologies and processes to inactivate viruses. This is done through a variety of methods, such as chemical treatments, physical treatments, and irradiation. These treatments are used to reduce the risk of contamination and to ensure the safety of products, such as pharmaceuticals, biologics, and medical devices. Viral inactivation is also used in the production of vaccines and other biologics. Viral inactivation is an important part of the biotechnology industry, as it helps to ensure the safety of products and reduce the risk of contamination. It is also used to improve the efficacy of products, such as vaccines. Some companies in the Viral Inactivation market include Merck, Sartorius, Lonza, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.